BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35179777)

  • 21. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Kim MH; Jung HJ; Park SI; Kim BJ
    Int J Gynaecol Obstet; 2021 Jul; 154(1):127-132. PubMed ID: 33368281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.
    Sowjanya AP; Paul P; Vedantham H; Ramakrishna G; Vidyadhari D; Vijayaraghavan K; Laksmi S; Sudula M; Ronnett BM; Das M; Shah KV; Gravitt PE;
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1373-8. PubMed ID: 19423518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study.
    Feng N; Ezechi O; Uwandu M; Abimbola BS; Vincent GD; Idigbe I; Okoli LC; Adesina M; Okwuzu J; Ahmed RA; Sokei J; Shaibu JO; Momoh AE; Sowunmi O; Labo-Popoola OH; ; Ohihoin G; David A; Nzeribe E; Olaleye O; Dong XP; Onwuamah CK
    BMC Public Health; 2022 Oct; 22(1):1922. PubMed ID: 36243709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
    Balasubramanian A; Kulasingam SL; Baer A; Hughes JP; Myers ER; Mao C; Kiviat NB; Koutsky LA
    J Low Genit Tract Dis; 2010 Jul; 14(3):185-95. PubMed ID: 20592553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
    BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
    Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women.
    Hernández-López R; Hermosillo L; León-Maldonado L; Velázquez-Cruz R; Torres-Ibarra L; Lazcano-Ponce E; Lörincz A; Wheeler CM; Bosch FX; Cuzick J; Rivera-Paredez B; Nedjai B; Salmerón J
    PLoS One; 2021; 16(7):e0254946. PubMed ID: 34288949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening.
    Kelly H; Mayaud P; Segondy M; Pant Pai N; Peeling RW
    Sex Transm Infect; 2017 Dec; 93(S4):S36-S45. PubMed ID: 29223961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
    Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
    BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India.
    Kuriakose S; Sabeena S; Binesh D; Abdulmajeed J; Ravishankar N; Ramachandran A; Vijaykumar B; Ameen N
    Int J Gynaecol Obstet; 2020 May; 149(2):219-224. PubMed ID: 32037539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis.
    Petignat P; Faltin DL; Bruchim I; Tramèr MR; Franco EL; Coutlée F
    Gynecol Oncol; 2007 May; 105(2):530-5. PubMed ID: 17335880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review.
    Stewart DE; Gagliardi A; Johnston M; Howlett R; Barata P; Lewis N; Oliver T; Mai V;
    J Obstet Gynaecol Can; 2007 Oct; 29(10):817-28. PubMed ID: 17915065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens.
    Ortiz AP; Romaguera J; Pérez CM; Otero Y; Soto-Salgado M; Méndez K; Valle Y; Da Costa M; Suarez E; Palefsky J; Tortolero-Luna G
    J Low Genit Tract Dis; 2013 Apr; 17(2):210-7. PubMed ID: 23422638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Risk Human Papillomavirus Messenger RNA Testing Using Urine, Cervicovaginal Self-Collected and Provider-Collected Cervical Samples Among Women in Mombasa, Kenya.
    Grabert BK; Islam JY; Mutua M; Kabare E; Manguro G; Waweru W; Mandaliya K; Shafi J; McClelland RS; Smith JS
    Sex Transm Dis; 2022 Nov; 49(11):782-785. PubMed ID: 35195617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age.
    Winer RL; Feng Q; Hughes JP; Yu M; Kiviat NB; O'Reilly S; Koutsky LA
    Sex Transm Dis; 2007 Jun; 34(6):371-7. PubMed ID: 17065848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.
    Castle PE; Gage JC; Partridge EE; Rausa A; Gravitt PE; Scarinci IC
    BMC Infect Dis; 2013 Jan; 13():5. PubMed ID: 23289357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.